Massive Bio Publishes The First Issue of Massive Bio Magazine
2022.11.22
Massive Bio, a leader in AI-powered cancer clinical trial enrollment, has published the second issue of Massive Bio magazine. The publication, which had a successful debut in August, features a variety of content for cancer patients and their families, clinicians, and the business community. Featured content in the second issue includes updates on Massive Bio, the latest oncology therapies, cancer and lifestyle, and technology in cancer treatment, as well as stories about cancer patients and their caregivers and advocates.
Recent In Massive Bio
Massive Bio’s Co-Founder Dr. Arturo Loaiza-Bonilla Participates in Europe’s Leading Health Tech Event
2023.12.05
Further Group Collaborates with Massive Bio, Integrating Health Solutions for the Insurance Industry to Boost Access to Cancer Clinical Trials Globally
2023.12.05
Massive Bio and Health in Code Collaborate to Enhance Personalized Oncology Treatment Through Advanced Genomic Testing
2023.12.05
Massive Bio and ONCOassist® Announce Strategic Partnership at ESMO 2023
2023.12.05
Cagatay Culcuoglu, Co-Founder of Massive Bio, to Speak at ‘Innovation in Oncology’ Event
2023.12.05